Uncertainty In Patent Term Extension For Biologics
When Congress enacted the Biologics Price Competition and Innovation Act of 2009, it created an artificial act of infringement for the submission of a biosimilar application but was silent as to...To view the full article, register now.
Already a subscriber? Click here to view full article